Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- mice.

Homozygous deletion of the gene of the neuronal glucose transporter GLUT3 (Slc2a3) in mice results in embryonic lethality, whereas heterozygotes (Slc2a3+/-) are viable. Here, we describe the characterization of heterozygous mice with regard to neuronal function, glucose homeostasis, and, since GLUT3 might be a component of the neuronal glucose-sensing mechanism, food intake and energy balance. Levels of GLUT3 mRNA and protein in brain were reduced by 50% in Slc2a3+/- mice. Electrographic features examined by electroencephalographic recordings give evidence for slightly but significantly enhanced cerebrocortical activity in Slc2a3+/- mice. In addition, Slc2a3+/- mice were slightly more sensitive to an acoustic startle stimulus (elevated startle amplitude and reduced prepulse inhibition). However, systemic behavioral testing revealed no other functional abnormalities, e.g., in coordination, reflexes, motor abilities, anxiety, learning, and memory. Furthermore, no differences in body weight, blood glucose, and insulin levels were detected between wild-type and Slc2a3+/- littermates. Food intake as monitored randomly or after intracerebroventricular administration of 2-deoxyglucose or d-glucose, or food choice for carbohydrates/fat was not affected in Slc2a3+/- mice. Taken together, our data indicate that, in contrast to Slc2a1, a single allele of Slc2a3 is sufficient for maintenance of neuronal energy supply, motor abilities, learning and memory, and feeding behavior.

[1]  S. Devaskar,et al.  Glucose transporter isoform-3-null heterozygous mutation causes sexually dimorphic adiposity with insulin resistance. , 2008, American journal of physiology. Endocrinology and metabolism.

[2]  A. Schousboe,et al.  Energy substrates to support glutamatergic and GABAergic synaptic function: Role of glycogen, glucose and lactate , 2007, Neurotoxicity Research.

[3]  J. Klepper,et al.  GLUT1 deficiency syndrome – 2007 update , 2007, Developmental medicine and child neurology.

[4]  J. Rottman,et al.  Glucose kinetics and exercise tolerance in mice lacking the GLUT4 glucose transporter , 2007, The Journal of physiology.

[5]  S. Vannucci,et al.  Supply and Demand in Cerebral Energy Metabolism: The Role of Nutrient Transporters , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  B. Shin,et al.  Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction. , 2007, American journal of physiology. Endocrinology and metabolism.

[7]  R. C. Honey,et al.  Revisiting places passed: Sensitization of exploratory activity in rats with hippocampal lesions , 2007, Quarterly journal of experimental psychology.

[8]  C. Meyer,et al.  Ablation of the cholesterol transporter adenosine triphosphate-binding cassette transporter G1 reduces adipose cell size and protects against diet-induced obesity. , 2007, Endocrinology.

[9]  E. Schleicher,et al.  Leptin Down-regulates Insulin Action through Phosphorylation of Serine-318 in Insulin Receptor Substrate 1 1. Leptin Stimulates Ser-318 Phosphorylation in Insulin Receptor Substrate 1 , 2022 .

[10]  Sylvia Ortmann,et al.  Hyperphagia, lower body temperature, and reduced running wheel activity precede development of morbid obesity in New Zealand obese mice. , 2006, Physiological genomics.

[11]  J. Noebels,et al.  A mouse model for Glut-1 haploinsufficiency. , 2006, Human molecular genetics.

[12]  H. Preissl,et al.  Tissue selectivity of insulin detemir action in vivo , 2006, Diabetologia.

[13]  Hong Yang,et al.  Glut‐1 deficiency syndrome: Clinical, genetic, and therapeutic aspects , 2005, Annals of neurology.

[14]  D. Wasserman,et al.  Control of Exercise-stimulated Muscle Glucose Uptake by GLUT4 Is Dependent on Glucose Phosphorylation Capacity in the Conscious Mouse* , 2004, Journal of Biological Chemistry.

[15]  A. Schürmann,et al.  The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. , 2004, JPEN. Journal of parenteral and enteral nutrition.

[16]  Angus M. Brown Brain glycogen re‐awakened , 2004, Journal of neurochemistry.

[17]  V. Routh,et al.  Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. , 2004, Diabetes.

[18]  P. Garnier,et al.  Hypoglycemic Neuronal Death and Cognitive Impairment Are Prevented by Poly(ADP-Ribose) Polymerase Inhibitors Administered after Hypoglycemia , 2003, The Journal of Neuroscience.

[19]  D. Montag,et al.  Severe cognitive and motor coordination deficits 
in Tenascin‐R‐deficient mice , 2003, Genes, brain, and behavior.

[20]  M. Schachner,et al.  Misguided Axonal Projections, Neural Cell Adhesion Molecule 180 mRNA Upregulation, and Altered Behavior in Mice Deficient for the Close Homolog of L1 , 2002, Molecular and Cellular Biology.

[21]  J. Rawlins,et al.  Anxiolytic effects of cytotoxic hippocampal lesions in rats. , 2002, Behavioral neuroscience.

[22]  M. Quirk,et al.  Requirement for Hippocampal CA3 NMDA Receptors in Associative Memory Recall , 2002, Science.

[23]  J. McArdle,et al.  Convergence of pre- and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus. , 2001, Diabetes.

[24]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[25]  F. Hanefeld,et al.  Autosomal dominant Glut‐1 deficiency syndrome and familial epilepsy , 2001, Annals of neurology.

[26]  J. Rawlins,et al.  Cytotoxic lesions of the hippocampus increase social investigation but do not impair social-recognition memory , 2001, Experimental Brain Research.

[27]  H. Joost,et al.  The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members , 2001, Molecular membrane biology.

[28]  S. Cushman,et al.  Overexpression of the glucose transporter GLUT4 in adipose cells interferes with insulin‐stimulated translocation , 1999, FEBS letters.

[29]  P. Magistretti,et al.  Astrocytes Couple Synaptic Activity to Glucose Utilization in the Brain. , 1999, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[30]  R. Schliebs,et al.  Insulin‐sensitive GLUT4 glucose transporters are colocalized with GLUT3‐expressing cells and demonstrate a chemically distinct neuron‐specific localization in rat brain , 1999, Journal of neuroscience research.

[31]  P. Magistretti,et al.  Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[32]  V. Routh,et al.  Brain glucose sensing and body energy homeostasis: role in obesity and diabetes. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[33]  R G Shulman,et al.  Energy on Demand , 1999, Science.

[34]  E. Fisher,et al.  Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment , 1997, Mammalian Genome.

[35]  A. McCall,et al.  Ultrastructural localization of GLUT 1 and GLUT 3 glucose transporters in rat brain , 1997, Journal of neuroscience research.

[36]  P. Magistretti,et al.  Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. McCall,et al.  Immunohistochemical localization of the neuron-specific glucose transporter (GLUT3) to neuropil in adult rat brain , 1994, Brain Research.

[38]  P. Trayhurn,et al.  Rapid chemiluminescent detection of facilitative glucose transporter mRNAs (GLUTs 1-4) with digoxigenin end-labelled oligonucleotides. , 1994, Biochemical Society transactions.

[39]  P. Ferré,et al.  Glucose transporter 2 (GLUT 2): expression in specific brain nuclei , 1994, Brain Research.

[40]  G. Milligan,et al.  Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system. , 1993, Biochemical and biophysical research communications.

[41]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[42]  Hans-Peter Lipp,et al.  A new computer program for detailed off-line analysis of swimming navigation in the Morris water maze , 1992, Journal of Neuroscience Methods.

[43]  S. Vannucci,et al.  Expression of mouse-GLUT3 and human-GLUT3 glucose transporter proteins in brain. , 1992, Biochemical and biophysical research communications.

[44]  L. Drewes,et al.  Neurons and microvessels express the brain glucose transporter protein GLUT3. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Kornhauser,et al.  Glucose transporter expression in brain. cDNA sequence of mouse GLUT3, the brain facilitative glucose transporter isoform, and identification of sites of expression by in situ hybridization. , 1992, The Journal of biological chemistry.

[46]  S. Harik,et al.  Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. , 1991, The New England journal of medicine.

[47]  T. Wieloch Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. , 1985, Science.

[48]  R. Morris Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.

[49]  F. Goodwin,et al.  Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines , 1980, Pharmacology Biochemistry and Behavior.

[50]  J. Noebels,et al.  A mouse model for Glut1 haploinsufficiency , 2006 .

[51]  E. McDermott,et al.  Impaired neuronal glucose uptake in pathogenesis of schizophrenia - can GLUT 1 and GLUT 3 deficits explain imaging, post-mortem and pharmacological findings? , 2005, Medical hypotheses.

[52]  R. Lister The use of a plus-maze to measure anxiety in the mouse , 2004, Psychopharmacology.

[53]  Conrad C. Huang,et al.  BayGenomics: a resource of insertional mutations in mouse embryonic stem cells , 2003, Nucleic Acids Res..

[54]  Bryan Kolb,et al.  Analysis of Behavior in Laboratory Rodents , 1999 .